表紙
市場調査レポート

皮膚科における治験募集:尋常性座瘡が最大の患者数を有するも多くの治験がアトピー性皮膚炎に注目

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers

発行 GBI Research 商品コード 216704
出版日 ページ情報 英文 89 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
皮膚科における治験募集:尋常性座瘡が最大の患者数を有するも多くの治験がアトピー性皮膚炎に注目 Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
出版日: 2011年10月03日 ページ情報: 英文 89 Pages
概要

製薬会社は、有望な治療分野、特定の適応のアンメットニーズ、患者の確保などの要素を加味して治験を実施します。皮膚科において治験最大数が実施されているのがアトピー性皮膚炎で過去10年で72件が実施されました。これに尋常性座瘡の40件、帯状疱疹28件、皮膚カンジダ症20件とつづきます。

当レポートでは、皮膚科における治験動向について調査し、尋常性座瘡、アトピー性皮膚炎、帯状疱疹、皮膚カンジダ症、脱毛症のセグメント別治験動向、平均被験者数、地域別動向などをまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 皮膚科における治験募集:イントロダクション

第3章 概要

  • 適応別治験シェア:2000〜2010年
  • 大手製薬会社による治験:2000〜2010年
  • 主な適応のための被験者募集:2000〜2010年

第4章 尋常性座瘡のための治験と被験者募集

  • イントロダクション
  • 尋常性座瘡の治験数
    • 相別
    • 治験依頼者別
    • 地域別
    • 年別
  • 尋常性座瘡の有病人口:2010〜2017年
    • ブラジル
    • インド
    • 中国
  • 尋常性座瘡の被験者募集
    • 治験段階別
    • 治験依頼者別
    • 地域別
    • 年別
  • 治験当たりに募集された被験者の平均数
    • 開発段階別
    • 治験年別

第5章 アトピー性皮膚炎の治験と被験者募集

  • イントロダクション
  • アトピー性皮膚炎の治験数
    • 相別
    • 治験依頼者別
    • 地域別
    • 年別
  • アトピー性皮膚炎の有病人口:2010〜2017年
    • ブラジル
    • インド
    • 中国
  • アトピー性皮膚炎の被験者募集
    • 治験段階別
    • 治験依頼者別
    • 地域別
    • 年別
  • 治験当たりに募集された被験者の平均数
    • 開発段階別
    • 治験年別

第6章 皮膚カンジダ症の治験と被験者募集

  • イントロダクション
  • 皮膚カンジダ症の治験数
    • 相別
    • 治験依頼者別
    • 地域別
    • 年別
  • 皮膚カンジダ症の被験者募集
    • 治験段階別
    • 治験依頼者別
    • 地域別
    • 年別
  • 治験当たりに募集された被験者の平均数
    • 開発段階別
    • 治験年別

第7章 帯状疱疹の治験と被験者募集

  • イントロダクション
  • 帯状疱疹の治験数
    • 相別
    • 治験依頼者別
    • 地域別
    • 年別
  • 帯状疱疹の有病人口:2010〜2017年
    • ブラジル
    • インド
    • 中国
  • 帯状疱疹の被験者募集
    • 治験段階別
    • 治験依頼者別
    • 地域別
    • 年別
  • 治験当たりに募集された被験者の平均数
    • 開発段階別
    • 治験年別

第8章 脱毛症の治験と被験者募集

  • イントロダクション
  • 脱毛症の治験数
    • 相別
    • 治験依頼者別
    • 地域別
    • 年別
  • 脱毛症の有病人口:2010〜2017年
    • ブラジル
    • インド
    • 中国
  • 脱毛症の被験者募集
    • 治験段階別
    • 治験依頼者別
    • 地域別
    • 年別
  • 治験当たりに募集された被験者の平均数
    • 開発段階別
    • 治験年別

第9章 付録

図表

目次
Product Code: GBIHC155MR

Abstract

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers

Summary

GBI Research's report 'Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers' provides an in-depth analysis of the current patient recruitment scenario for major indications under dermatology. The report analyzes a number of clinical trials conducted for major indications. It provides information about the total number of clinical trials conducted by phase, geography, major sponsors and clinical trials per year. An analysis of the total number of patients recruited for major indications is given. The report analyzes total number of patients recruited by phase of clinical trial, geography and major sponsors. An analysis of the average number of patients recruited per trial per year for various indications is also given.

Clinical trials are being conducted on dermatological diseases in order to find better treatment options. There has been an increase in the number of clinical trials conducted due to a rise in the prevalence of dermatology disorders. A clinical trial is one of the most critical parts of the drug development process.

Scope

The report analyzes the clinical trial recruitment trends for pharmaceutical companies for various dermatological trials. Its scope includes -

  • Insight on clinical trials conducted for major indications of dermatological diseases such as acne vulgaris, atopic dermatitis, candidiasis, herpes zoster and alopecia between 2000 and 2010.
  • The status of patient recruitment by geography, sponsor company, year and stage of development.
  • Analysis of the average number of patients recruited per trial for major indications per year.
  • Analysis of the average number of patients recruited per trial for major indications by stage of development.
  • The prevalence population in India, China and Brazil for all major indications from 2010 to 2017.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

  • Identify and understand the status of clinical trials conducted for major dermatology indications from 2000 to 2010.
  • Build understanding of patient recruitment status by geography, sponsor company, year and stage of development.
  • Identify the prevalence population for major indications until 2017.
  • Identify the average number of patients recruited by stage of development and across years for all major indications.
  • Identify the indication for which the most trials are conducted and most patients are recruited.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Clinical Trial Recruitment in Dermatology - Introduction

  • 2.1. GBI Research Report Guidance

3. Clinical Trial Recruitment in Dermatology - Overview

  • 3.1. Clinical Trial Share by Indication, 2000-2010
  • 3.2. Clinical Trials by Major Pharmaceutical Companies, 2000-2010
  • 3.3. Patient Recruitment for Major Indications, 2000-2010

4. Clinical Trials and Patient Recruitment for Acne Vulgaris

  • 4.1. Introduction
  • 4.2. Number of Clinical Trials for Acne Vulgaris
    • 4.2.1. Number of Clinical Trials by Phase
    • 4.2.2. Number of Clinical Trials for Acne Vulgaris by Major Sponsors
    • 4.2.3. Number of Clinical Trials for Acne Vulgaris by Geography
    • 4.2.4. Number of Clinical Trials for Acne Vulgaris by Year
  • 4.3. Prevalence Population for Acne Vulgaris, 2010-2017
    • 4.3.1. Brazil
    • 4.3.2. India
    • 4.3.3. China
  • 4.4. Patient Recruitment for Acne Vulgaris
    • 4.4.1. Number of Patients Recruited by Phase of Clinical Trials
    • 4.4.2. Number of Patients Recruited by Major Sponsors
    • 4.4.3. Number of Patients Recruited by Geography
    • 4.4.4. Number of Patients Recruited per Year
  • 4.5. Average Number of Patients Recruited per Trial
    • 4.5.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 4.5.2. Average Number of Patients Recruited per Trial per Year

5. Clinical Trials and Patient Recruitment for Atopic Dermatitis

  • 5.1. Introduction
  • 5.2. Number of Clinical Trials for Atopic Dermatitis
    • 5.2.1. Number of Clinical Trials by Phase
    • 5.2.2. Number of Clinical Trials by Sponsor
    • 5.2.3. Number of Clinical Trials by Geography
    • 5.2.4. Number of Clinical Trials by Year
  • 5.3. Prevalence Population for Atopic Dermatitis, 2010-2017
    • 5.3.1. Brazil
    • 5.3.2. India
    • 5.3.3. China
  • 5.4. Patient Recruitment for Atopic Dermatitis
    • 5.4.1. Number of Patients Recruited by Phase of Clinical Trial
    • 5.4.2. Number of Patients Recruited by Sponsor
    • 5.4.3. Number of Patients Recruited by Geography
    • 5.4.4. Number of Patients Recruited per Year
  • 5.5. Average Number of Patients Recruited per Trial
    • 5.5.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 5.5.2. Average Number of Patients Recruited per Trial per Year

6. Clinical Trials and Patient Recruitment for Candidiasis

  • 6.1. Introduction
  • 6.2. Number of Clinical Trials for Candidiasis
    • 6.2.1. Number of Clinical Trials by Phase
    • 6.2.2. Number of Clinical Trials by Major Sponsor
    • 6.2.3. Number of Clinical Trials by Geography
    • 6.2.4. Number of Clinical Trials by Year
  • 6.3. Patient Recruitment for Candidiasis
    • 6.3.1. Number of Patients Recruited by Phase of Clinical Trial
    • 6.3.2. Number of Patients Recruited by Major Sponsors
    • 6.3.3. Number of Patients Recruited by Geography
    • 6.3.4. Number of Patients Recruited per Year
  • 6.4. Average Number of Patients Recruited per Trial
    • 6.4.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 6.4.2. Average Number of Patients Recruited per Trial per Year

7. Clinical Trials and Patient Recruitment for Herpes Zoster

  • 7.1. Introduction
  • 7.2. Number of Clinical Trials for Herpes Zoster
    • 7.2.1. Number of Clinical Trials by Phase
    • 7.2.2. Number of Clinical Trials by Major Sponsors
    • 7.2.3. Number of Clinical Trials by Geography
    • 7.2.4. Number of Clinical Trials by Year
  • 7.3. Prevalence Population for Herpes Zoster, 2010-2017
    • 7.3.1. Brazil
    • 7.3.2. India
    • 7.3.3. China
  • 7.4. Patient Recruitment for Herpes Zoster
    • 7.4.1. Number of Patients Recruited by Phase of Clinical Trial
    • 7.4.2. Number of Patients Recruited by Major Sponsors
    • 7.4.3. Number of Patients Recruited by Geography
    • 7.4.4. Number of Patients Recruited per Year
  • 7.5. Average Number of Patients Recruited per Trial
    • 7.5.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 7.5.2. Average Number of Patients Recruited per Trial per Year

8. Clinical Trials and Patient Recruitment for Alopecia

  • 8.1. Introduction
  • 8.2. Number of Clinical Trials for Alopecia
    • 8.2.1. Number of Clinical Trials by Phase
    • 8.2.2. Number of Clinical Trials by Sponsor
    • 8.2.3. Number of Clinical Trials by Geography
    • 8.2.4. Number of Clinical Trials by Year
  • 8.3. Prevalence Population for Alopecia, 2010-2017
    • 8.3.1. Brazil
    • 8.3.2. India
    • 8.3.3. China
  • 8.4. Patient Recruitment for Alopecia
    • 8.4.1. Number of Patients Recruited by Phase of Clinical Trial
    • 8.4.2. Number of Patients Recruited by Major Sponsors
    • 8.4.3. Number of Patients Recruited by Geography
    • 8.4.4. Number of Patients Recruited per Year
  • 8.5. Average Number of Patients Recruited per Trial
    • 8.5.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 8.5.2. Average Number of Patients Recruited per Trial per Year

9. Clinical Trial Recruitment in Dermatology - Appendix

  • 9.1. Market Definitions
  • 9.2. Abbreviations
  • 9.3. Research Methodology
    • 9.3.1. Clinical Trials Overview
    • 9.3.2. Number of Clinical Trials
    • 9.3.3. Patient Recruitment Status
    • 9.3.4. Prevalence of Disease in India, China and Brazil (2010-2017)
  • 9.4. Coverage
  • 9.5. Secondary Research
  • 9.6. Primary Research
  • 9.7. Expert Panel Validation
  • 9.8. Contact Us
  • 9.9. Disclaimer
  • 9.10. Sources

List of Tables

  • Table 1: Clinical Trial Recruitment in Dermatology, Global, Ongoing Trials by Indication, 2000-2010
  • Table 2: Clinical Trial Recruitment in Dermatology, Asia, Ongoing Trials by Indication, 2000-2010
  • Table 3: Clinical Trial Recruitment in Dermatology, Europe, Ongoing Trials by Indication, 2000-2010
  • Table 4: Clinical Trial Recruitment in Dermatology, North America, Ongoing Trials by Indication, 2000-2010
  • Table 5: Clinical Trial Recruitment in Dermatology, Global, Clinical Trials by Major Pharmaceutical Companies, 2000-2010
  • Table 6: Clinical Trial Recruitment in Dermatology, Global, Number of Patients Recruited for Major Indications, 2000-2010
  • Table 7: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials by Phase, 2000-2010
  • Table 8: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials by Major Sponsors, 2000-2010
  • Table 9: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials by Geography, 2000-2010
  • Table 10: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials per Year, 2000-2010
  • Table 11: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Brazil, Prevalence Population, million, 2010-2017
  • Table 12: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, India, Prevalence Population, million, 2010-2017
  • Table 13: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, China, Prevalence Population, million, 2010-2017
  • Table 14: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited by Phase, 2000-2010
  • Table 15: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited by Major Sponsors, 2000-2010
  • Table 16: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited by Geography, 2000-2010
  • Table 17: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited per Year, 2000-2010
  • Table 18: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Table 19: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Table 20: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials, 2000-2010
  • Table 21: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials by Major Sponsors, 2000-2010
  • Table 22: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials by Geography, 2000-2010
  • Table 23: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials per Year, 2000-2010
  • Table 24: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Brazil, Prevalence Population, million, 2010-2017
  • Table 25: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, India, Prevalence Population, million, 2010-2017
  • Table 26: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, China, Prevalence Population, million, 2010-2017
  • Table 27: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited by Phase, 2000-2010
  • Table 28: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited by Major Sponsors, 2000-2010
  • Table 29: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited by Geography, 2000-2010
  • Table 30: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited per Year, 2000-2010
  • Table 31: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Table 32: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Table 33: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials by Phase, 2000-2010
  • Table 34: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials by Major Sponsors, 2000-2010
  • Table 35: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials by Geography, 2000-2010
  • Table 36: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials per Year, 2000-2010
  • Table 37: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited by Phase, 2000-2010
  • Table 38: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited by Major Sponsors, 2000-2010
  • Table 39: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited by Geography, 2000-2010
  • Table 40: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited per Year, 2000-2010
  • Table 41: Clinical Trial Recruitment in Dermatology, Candidiasis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Table 42: Clinical Trial Recruitment in Dermatology, Candidiasis, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Table 43: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials by Phase, 2000-2010
  • Table 44: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials by Major Sponsors, 2000-2010
  • Table 45: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials by Geography, 2000-2010
  • Table 46: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials per Year, 2000-2010
  • Table 47: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Brazil, Prevalence Population, million, 2010-2017
  • Table 48: Clinical Trial Recruitment in Dermatology, Herpes Zoster, India, Prevalence Population, million, 2010-2017
  • Table 49: Clinical Trial Recruitment in Dermatology, Herpes Zoster, China, Prevalence Population, million, 2010-2017
  • Table 50: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited by Phase, 2000-2010
  • Table 51: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited by Major Sponsors, 2000-2010
  • Table 52: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited by Geography, 2000-2010
  • Table 53: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited per Year, 2000-2010
  • Table 54: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Table 55: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Table 56: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Clinical Trials by Phase, 2000-2010
  • Table 57: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Clinical Trials by Major Sponsors, 2000-2010
  • Table 58: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Clinical Trials by Geography, 2000-2010
  • Table 59: Clinical Trial Recruitment in Dermatology, Alopecia, Brazil, Prevalence Population, million, 2010-2017
  • Table 60: Clinical Trial Recruitment in Dermatology, Alopecia, India, Prevalence Population, million, 2010-2017
  • Table 61: Clinical Trial Recruitment in Dermatology, Alopecia, China, Prevalence Population, million, 2010-2017
  • Table 62: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited by Phase, 2000-2010
  • Table 63: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited by Major Sponsors, 2000-2010
  • Table 64: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited by Geography, 2000-2010
  • Table 65: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited per Year, 2000-2010
  • Table 66: Clinical Trial Recruitment in Dermatology, Alopecia, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Table 67: Clinical Trial Recruitment in Dermatology, Alopecia, Average Number of Patients Recruited per Trial per Year, 2000-2010

List of Figures

  • Figure 1: Clinical Trial Recruitment in Dermatology, Global, Ongoing Trials by Indication (%), 2000-2010
  • Figure 2: Clinical Trial Recruitment in Dermatology, Asia, Ongoing Trials by Indication, 2000-2010
  • Figure 3: Clinical Trial Recruitment in Dermatology, Europe, Ongoing Trials by Indication, 2000-2010
  • Figure 4: Clinical Trial Recruitment in Dermatology, North America, Ongoing Trials by Indication, 2000-2010
  • Figure 5: Clinical Trial Recruitment in Dermatology, Global, Clinical Trials by Major Pharmaceutical Companies (%), 2000-2010
  • Figure 6: Clinical Trial Recruitment in Dermatology, Global, Number of Patients Recruited for Major Indications, 2000-2010
  • Figure 7: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials by Phase (%), 2000-2010
  • Figure 8: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials by Major Sponsors (%), 2000-2010
  • Figure 9: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials by Geography (%), 2000-2010
  • Figure 10: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Clinical Trials per Year, 2000-2010
  • Figure 11: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Brazil, Prevalence Population, million, 2010-2017
  • Figure 12: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, India, Prevalence Population, million, 2010-2017
  • Figure 13: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, China, Prevalence Population, million, 2010-2017
  • Figure 14: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited by Phase (%), 2000-2010
  • Figure 15: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited by Major Sponsors (%), 2000-2010
  • Figure 16: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited by Geography, (%), 2000-2010
  • Figure 17: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Total Number of Patients Recruited per Year, 2000-2010
  • Figure 18: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Figure 19: Clinical Trial Recruitment in Dermatology, Acne Vulgaris, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Figure 20: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials (%), 2000-2010
  • Figure 21: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials by Major Sponsors (%), 2000-2010
  • Figure 22: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials by Geography (%), 2000-2010
  • Figure 23: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Clinical Trials per Year, 2000-2010
  • Figure 24: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Brazil, Prevalence Population, million, 2010-2017
  • Figure 25: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, India, Prevalence Population, million, 2010-2017
  • Figure 26: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, China, Prevalence Population, million, 2010-2017
  • Figure 27: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited by Phase (%), 2000-2010
  • Figure 28: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited by Major Sponsors (%), 2000-2010
  • Figure 29: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited by Geography (%), 2000-2010
  • Figure 30: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Total Number of Patients Recruited per Year, 2000-2010
  • Figure 31: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Figure 32: Clinical Trial Recruitment in Dermatology, Atopic Dermatitis, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Figure 33: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials by Phase (%), 2000-2010
  • Figure 34: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials by Major Sponsors (%), 2000-2010
  • Figure 35: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials by Geography (%), 2000-2010
  • Figure 36: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Clinical Trials per Year, 2000-2010
  • Figure 37: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited by Phase (%), 2000-2010
  • Figure 38: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited by Major Sponsors (%), 2000-2010
  • Figure 39: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited by Geography (%), 2000-2010
  • Figure 40: Clinical Trial Recruitment in Dermatology, Candidiasis, Total Number of Patients Recruited per Year, 2000-2010
  • Figure 41: Clinical Trial Recruitment in Dermatology, Candidiasis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Figure 42: Clinical Trial Recruitment in Dermatology, Candidiasis, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Figure 43: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials by Phase (%), 2000-2010
  • Figure 44: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials by Major Sponsors, 2000-2010
  • Figure 45: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials by Geography, 2000-2010
  • Figure 46: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Clinical Trials per Year, 2000-2010
  • Figure 47: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Brazil, Prevalence Population, million, 2010-2017
  • Figure 48: Clinical Trial Recruitment in Dermatology, Herpes Zoster, India, Prevalence Population, million, 2010-2017
  • Figure 49: Clinical Trial Recruitment in Dermatology, Herpes Zoster, China, Prevalence Population, million, 2010-2017
  • Figure 50: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited by Phase, 2000-2010
  • Figure 51: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited by Major Sponsors (%), 2000-2010
  • Figure 52: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited by Geography, 2000-2010
  • Figure 53: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Total Number of Patients Recruited per Year, 2000-2010
  • Figure 54: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Figure 55: Clinical Trial Recruitment in Dermatology, Herpes Zoster, Average Number of Patients Recruited per Trial per Year, 2000-2010
  • Figure 56: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Clinical Trials by Phase (%), 2000-2010
  • Figure 57: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Clinical Trials by Major Sponsors (%), 2000-2010
  • Figure 58: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Clinical Trials by Geography (%), 2000-2010
  • Figure 59: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Clinical Trials per Year, 2000-2010
  • Figure 60: Clinical Trial Recruitment in Dermatology, Alopecia, Brazil, Prevalence Population, million, 2010-2017
  • Figure 61: Clinical Trial Recruitment in Dermatology, Alopecia, India, Prevalence Population, million, 2010-2017
  • Figure 62: Clinical Trial Recruitment in Dermatology, Alopecia, China, Prevalence Population, million, 2010-2017
  • Figure 63: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited by Phase (%), 2000-2010
  • Figure 64: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited by Major Sponsors (%), 2000-2010
  • Figure 65: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited by Geography (%), 2000-2010
  • Figure 66: Clinical Trial Recruitment in Dermatology, Alopecia, Total Number of Patients Recruited per Year, 2000-2010
  • Figure 67: Clinical Trial Recruitment in Dermatology, Alopecia, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2010
  • Figure 68: Clinical Trial Recruitment in Dermatology, Alopecia, Average Number of Patients Recruited per Trial per Year, 2000-2010
Back to Top